T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amazon
AMZN
$2.5T
| $15.8B | 3.35% |
441,847,220
-15,981,480
| -3% | -$541M |
|
2
Microsoft
MSFT
$2.84T
| $9.11B | 1.93% |
178,075,029
+10,922,600
| +7% | +$568M |
|
3
Meta Platforms (Facebook)
META
$1.51T
| $8.15B | 1.73% |
71,321,911
+3,380,806
| +5% | +$390M |
|
4
Booking.com
BKNG
$138B
| $7.62B | 1.61% |
152,527,650
+4,553,225
| +3% | +$236M |
|
5
Danaher
DHR
$135B
| $7.04B | 1.49% |
103,670,188
-5,796,856
| -5% | -$379M |
|
6
Alphabet (Google) Class C
GOOG
$3.9T
| $6.76B | 1.43% |
195,308,640
+2,891,880
| +2% | +$104M |
|
|
7
Alphabet (Google) Class A
GOOGL
$3.91T
| $5.67B | 1.2% |
161,240,100
-292,720
| -0.2% | -$10.7M |
|
8
Visa
V
$677B
| $5.6B | 1.19% |
75,438,095
+1,651,780
| +2% | +$129M |
|
|
9
Apple
AAPL
$4.89T
| $5.59B | 1.19% |
234,036,284
+28,984,872
| +14% | +$720M |
|
10
Bristol-Myers Squibb
BMY
$127B
| $5.31B | 1.13% |
72,255,849
+7,001,439
| +11% | +$495M |
|
11
UnitedHealth
UNH
$382B
| $4.68B | 0.99% |
33,178,758
-3,370,770
| -9% | -$449M |
|
12
Boeing
BA
$165B
| $4.38B | 0.93% |
33,753,582
-3,446,291
| -9% | -$449M |
|
13
Philip Morris
PM
$301B
| $4.35B | 0.92% |
42,789,043
+4,030,384
| +10% | +$402M |
|
|
MRSH
14
Marsh
MRSH
$86.3B
| $4.27B | 0.9% |
62,360,917
-4,298,296
| -6% | -$276M |
|
15
GE Aerospace
GE
$367B
| $3.97B | 0.84% |
26,293,060
-748,377
| -3% | -$109M |
|
|
AET
16
DELISTED
Aetna Inc
AET
| $3.96B | 0.84% |
32,438,338
+3,108,173
| +11% | +$357M |
|
17
Morgan Stanley
MS
$337B
| $3.95B | 0.84% |
151,901,831
+9,713,109
| +7% | +$254M |
|
|
18
Pfizer
PFE
$140B
| $3.85B | 0.82% |
115,396,261
-28,234,812
| -20% | -$901M |
|
|
AGN
19
DELISTED
Allergan plc
AGN
| $3.83B | 0.81% |
16,590,775
-4,475,883
| -21% | -$1.03B |
|
20
JPMorgan Chase
JPM
$939B
| $3.74B | 0.79% |
60,244,434
+4,756,130
| +9% | +$297M |
|
21
Intuitive Surgical
ISRG
$121B
| $3.59B | 0.76% |
48,898,242
-1,476,531
| -3% | -$104M |
|
22
Lowe's Companies
LOW
$116B
| $3.55B | 0.75% |
44,842,201
+1,105,134
| +3% | +$85.5M |
|
23
American Tower
AMT
$77.7B
| $3.5B | 0.74% |
30,807,166
-715,110
| -2% | -$76.1M |
|
24
ExxonMobil
XOM
$651B
| $3.5B | 0.74% |
37,303,332
+5,984,988
| +19% | +$529M |
|
25
Mastercard
MA
$477B
| $3.5B | 0.74% |
39,689,403
+235,024
| +0.6% | +$22.4M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.